Guidetti Anna

Research Fellow
Competition sector


University email address



  • Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma / A. Dodero, A. Guidetti, A. Tucci, F. Barretta, M. Novo, L. Devizzi, A. Re, A. Passi, A. Pellegrinelli, G. Pruneri, R. Miceli, A. Testi, M. Pennisi, M.C. Di Chio, P. Matteucci, C. Carniti, F. Facchetti, G. Rossi, P. Corradini. - In: LEUKEMIA. - ISSN 0887-6924. - (2019).
  • A Phase 2 multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy / M. Trněný, G. Verhoef, M.J. Dyer, D.B. Yehuda, C. Patti, M. Canales, A. Lopez, F.T. Awan, P.G. Montgomery, A. Janikova, A.M. Barbui, K. Sulek, M.J. Terol, J. Radford, A. Guidetti, M. Di Nicola, L. Siraudin, L. Hatteville, S. Schwab, C. Oprea, A.M. Gianni. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 103(2018 May 10). [Epub ahead of print]
  • Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma : long-term outcomes and graft-versus-host disease-free/relapse-free survival / F. Spina, T. Radice, C. De Philippis, M. Soldarini, M.C. Di Chio, A. Dodero, A. Guidetti, S. Viviani, P. Corradini. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - (2018 May 01). [Epub ahead of print]
  • Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma / A. Guidetti, A. Mazzocchi, R. Miceli, E.V.M. Paterno', F. Taverna, F. Spina, F. Crippa, L. Farina, P. Corradini, A..M. Gianni, S. Viviani. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - 62(2017 Nov), pp. 91-97.
  • High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression / F. Maura, A. Guidetti, A. Pellegrinelli, A. Dodero, M. Pennisi, C. Caprioli, A. Testi, L. Farina, N. Bolli, L.F. Devizzi, A. Cabras, P. Corradini. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - 6:11(2016 Nov), pp. e491.1-e491.4.